Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments

PURPOSE: It is advantageous to individualize high-dose methotrexate (HDMTX) to maintain adequate exposure while minimizing toxicities. Previously, we accomplished this through within-course dose adjustments. METHODS: In this study, we evaluated a strategy to individualize HDMTX based on clearance of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Pauley, Jennifer L., Panetta, John C., Crews, Kristine R., Pei, Deqing, Cheng, Cheng, McCormick, John, Howard, Scott C., Sandlund, John T., Jeha, Sima, Ribeiro, Raul, Rubnitz, Jeffrey, Pui, Ching-Hon, Evans, William E., Relling, Mary V.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2013
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3719000/
https://ncbi.nlm.nih.gov/pubmed/23760811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2206-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia